By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Denceptor Therapeutics 

c/o Abzena Holdings Limited
Babraham Research Campus
Babraham  Cambridge  CB22 3AT  United Kingdom
Phone: 44-0-1865-332-700 Fax: n/a


SEARCH JOBS

Denceptor Therapeutics will develop immunotherapeutic products to treat cancer and auto immune diseases using Baylor Scott & White Reasearch Institutes's dendritic cell receptor-targeting antibodies.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Kevin FitzGerald


Key Statistics


Email:
Ownership: Private

Web Site: Denceptor Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->